Hemoglobin C disease
hee-muh-gloh-bin C dih-zeez
Also known as: Hb C disease, Hemoglobin C disorder
At a Glance
What is Hemoglobin C disease?
Hemoglobin C disease is a genetic blood disorder that affects the red blood cells. It is caused by a mutation in the HBB gene, leading to the production of abnormal hemoglobin known as hemoglobin C. This condition primarily affects the circulatory system, as the abnormal hemoglobin can cause red blood cells to become rigid and form crystals. Over time, individuals with hemoglobin C disease may experience mild to moderate anemia and episodes of joint pain. Early symptoms often include fatigue and jaundice, while later symptoms can involve splenomegaly and gallstones. Early diagnosis is crucial to manage symptoms effectively and prevent complications. The condition can impact family life, especially if multiple family members are affected or carriers. Prognosis is generally good with proper management, and many individuals lead normal lives with minimal restrictions. However, some may require regular medical check-ups and interventions to manage symptoms. Daily life for affected individuals may involve monitoring for anemia-related symptoms and avoiding activities that could exacerbate joint pain.
Medical Definition
Hemoglobin C disease is a hemoglobinopathy resulting from a point mutation in the beta-globin gene, causing the substitution of lysine for glutamic acid at the sixth position of the beta-globin chain. Pathologically, this leads to the formation of intracellular hemoglobin C crystals and target cells on peripheral blood smears. It is classified under the broader category of hemoglobinopathies, alongside conditions like sickle cell disease. Epidemiologically, it is most prevalent in individuals of West African descent, with a lower incidence in other populations. The disease course is typically mild, with most individuals experiencing minimal symptoms. However, complications such as splenomegaly and cholelithiasis can occur, necessitating regular monitoring and supportive care.
Hemoglobin C disease Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Anemia in Hemoglobin C disease manifests as fatigue, pallor, and shortness of breath due to reduced oxygen delivery to tissues. The biological mechanism involves the formation of hemoglobin C crystals within red blood cells, leading to their premature destruction. Over time, anemia can become more pronounced, especially during periods of stress or illness. It affects daily life by limiting physical activity and causing chronic fatigue, but can be managed with folic acid supplementation and regular monitoring.
Splenomegaly presents as an enlarged spleen, which can cause abdominal discomfort or pain. This occurs because the spleen works harder to filter out the abnormal red blood cells that are destroyed prematurely. As the condition progresses, the spleen may continue to enlarge, potentially leading to hypersplenism. Daily life can be affected by discomfort and a feeling of fullness, and in severe cases, surgical intervention may be required.
Jaundice is characterized by yellowing of the skin and eyes due to elevated bilirubin levels from increased red blood cell breakdown. The biological mechanism involves hemolysis, which releases bilirubin into the bloodstream faster than the liver can process it. Over time, jaundice may fluctuate with the severity of hemolysis and liver function. It can cause discomfort and social stigma, but is often managed with hydration and monitoring of liver function.
Common
Gallstones can develop due to excess bilirubin from chronic hemolysis, leading to the formation of pigment stones. This occurs as the liver processes the increased bilirubin load, which can precipitate in the gallbladder. Over time, gallstones may cause biliary colic or cholecystitis if they obstruct the bile duct. They can significantly impact quality of life by causing pain and digestive issues, often necessitating dietary changes or surgical removal.
Fatigue in Hemoglobin C disease is a persistent feeling of tiredness and lack of energy. It results from anemia and the body's reduced ability to transport oxygen efficiently. This symptom can worsen with physical exertion or stress, leading to decreased productivity and quality of life. Management includes addressing the underlying anemia and ensuring adequate rest and nutrition.
Pallor is the noticeable paleness of the skin and mucous membranes due to reduced hemoglobin levels. It is caused by the decreased number of healthy red blood cells in circulation. Pallor can become more apparent during episodes of increased hemolysis or anemia. It may affect self-esteem and social interactions, but is generally managed by treating the underlying anemia.
Less Common
Bone pain may occur due to increased bone marrow activity as the body attempts to compensate for hemolysis. The biological mechanism involves marrow expansion and increased pressure within bones. Over time, this pain can become chronic and may be exacerbated by physical activity. It can limit mobility and daily functioning, but can be managed with pain relief medications and supportive care.
Individuals with Hemoglobin C disease may experience increased susceptibility to infections, particularly after splenectomy. This is due to the spleen's role in filtering bacteria and producing immune cells. Over time, the risk of infections can lead to frequent illnesses and complications. Preventive measures include vaccinations and prophylactic antibiotics to reduce infection risk.
What Causes Hemoglobin C disease?
Hemoglobin C disease is caused by a mutation in the HBB gene located on chromosome 11, which encodes the beta-globin subunit of hemoglobin. The normal function of the beta-globin protein is to bind with alpha-globin chains to form hemoglobin, which is responsible for oxygen transport in red blood cells. In hemoglobin C disease, a single point mutation results in the substitution of lysine for glutamic acid at the sixth position of the beta-globin chain. This mutation alters the protein's structure, leading to the formation of hemoglobin C instead of normal hemoglobin A. The presence of hemoglobin C causes red blood cells to become more rigid and less flexible, leading to their premature destruction in the spleen. This results in hemolytic anemia and the accumulation of bilirubin, causing jaundice. The rigid red blood cells can also cause microvascular occlusions, leading to tissue ischemia and pain. The immune system may respond to the altered red blood cells, causing mild inflammation. Although neuroinflammation is not a primary feature, chronic hemolysis can lead to oxidative stress, affecting various tissues. White matter degeneration is not a hallmark of this disease, but organ dysfunction can occur due to chronic anemia. Symptoms such as fatigue, splenomegaly, and gallstones appear due to the combination of hemolysis and microvascular complications. The pattern of symptoms is influenced by the balance between hemolysis and the body's compensatory mechanisms. Disease severity varies among patients due to genetic factors, the presence of coexisting hemoglobinopathies, and environmental influences.
How is Hemoglobin C disease Diagnosed?
Typical age of diagnosis: Hemoglobin C disease is typically diagnosed in early childhood or adolescence when symptoms such as mild hemolytic anemia or splenomegaly become apparent. Diagnosis often occurs following routine blood tests or when investigating symptoms like fatigue or jaundice. Family history of hemoglobinopathies may prompt earlier investigation. Newborn screening programs in some regions may also identify the condition at birth.
The clinician looks for symptoms such as mild anemia, splenomegaly, and occasional episodes of jaundice. A detailed family history of hemoglobinopathies is crucial, as it may indicate a hereditary pattern. Physical examination may reveal pallor, splenomegaly, or scleral icterus. This step helps determine the need for further hematological investigations and guides the clinician towards considering hemoglobinopathies.
Ultrasound is the primary imaging modality used to assess splenomegaly and exclude other causes of abdominal pain. Specific abnormalities such as an enlarged spleen are visible, which are consistent with hemolytic anemia. Imaging findings support the diagnosis by correlating with clinical symptoms and excluding other abdominal pathologies. Differential diagnoses such as liver disease or other causes of splenomegaly are considered and excluded based on imaging results.
Complete blood count and peripheral blood smear are ordered to assess anemia and red blood cell morphology. Biomarkers such as hemoglobin electrophoresis are sought to identify abnormal hemoglobin variants. Abnormal results show the presence of hemoglobin C and target cells on the blood smear. These results confirm the diagnosis and guide further genetic testing if needed.
The HBB gene is sequenced to identify mutations responsible for hemoglobin C disease. Specific mutations such as the substitution of lysine for glutamic acid at position 6 of the beta-globin chain are found. Genetic testing confirms the diagnosis by identifying the hemoglobin C mutation. Results inform family counseling regarding the hereditary nature of the disease and potential implications for family members.
Hemoglobin C disease Treatment Options
Folic acid is a vitamin supplement used to support red blood cell production. It works by aiding in the synthesis of nucleic acids, which are essential for erythropoiesis. Specific drugs used include daily folic acid tablets. Clinical evidence suggests that folic acid supplementation helps prevent folate deficiency in patients with chronic hemolytic anemia. Limitations include the need for long-term adherence and potential side effects like gastrointestinal discomfort.
Specific techniques include low-impact aerobic exercises and strength training. The therapeutic goals are to improve cardiovascular fitness and muscle strength. Sessions are typically conducted 2-3 times per week for 30-60 minutes. Measurable outcomes include improved exercise tolerance and reduced fatigue. Long-term benefits include enhanced quality of life and reduced risk of complications related to physical inactivity.
Indication for surgery includes severe splenomegaly causing significant symptoms or complications. The procedure involves the surgical removal of the spleen. Expected benefits include reduced hemolysis and improved hemoglobin levels. Surgical risks include infection and thrombosis, requiring careful post-operative monitoring. Post-operative care includes vaccinations and prophylactic antibiotics to prevent infections.
The care team includes hematologists, nutritionists, and social workers. Specific interventions provided are regular monitoring of hemoglobin levels and nutritional counseling. Psychosocial support strategies involve counseling and support groups for patients and families. Family education focuses on understanding the disease and managing symptoms. The long-term monitoring plan includes regular follow-ups to assess disease progression and treatment efficacy.
When to See a Doctor for Hemoglobin C disease
- Severe anemia — this can lead to life-threatening complications such as heart failure if not treated promptly.
- Sudden and severe pain episodes — these may indicate a vaso-occlusive crisis requiring immediate medical attention.
- Signs of stroke, such as sudden weakness or confusion — these require emergency care as they can result in permanent damage or death.
- Persistent fatigue — this may indicate worsening anemia and should be evaluated by a healthcare provider.
- Frequent infections — this could suggest splenic dysfunction and requires medical assessment.
- Jaundice — this may indicate increased hemolysis and should be monitored by a doctor.
- Mild fatigue — monitor energy levels and ensure adequate rest and nutrition.
- Occasional joint pain — monitor for worsening symptoms and consider over-the-counter pain relief if needed.
Hemoglobin C disease — Frequently Asked Questions
Is this condition hereditary?
Hemoglobin C disease is inherited in an autosomal recessive pattern, meaning both parents must carry a copy of the mutated gene. If both parents are carriers, there is a 25% chance with each pregnancy that the child will have the disease. De novo mutations are not a common cause of this condition. Carrier status can lead to mild symptoms and should be discussed with a healthcare provider. Genetic counseling is recommended for families to understand inheritance patterns and implications.
What is the life expectancy for someone with this condition?
Life expectancy is generally normal for individuals with Hemoglobin C disease, especially if diagnosed and managed early. Complications such as severe anemia or infections can worsen outcomes. Mortality is often related to severe complications like stroke or heart failure. Regular treatment and monitoring can significantly improve survival and quality of life. Patients should have realistic expectations about managing chronic symptoms and potential complications.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves a complete blood count and hemoglobin electrophoresis to identify abnormal hemoglobin types. The time from first symptoms to diagnosis can vary, often taking weeks to months. Hematologists are usually consulted for diagnosis and management. Delayed diagnosis may occur due to mild symptoms or lack of awareness. Confirmation is achieved through genetic testing or specific blood tests.
Are there any new treatments or clinical trials available?
Research is ongoing, with gene therapy and novel drug treatments showing promise. Clinical trials are exploring these options, and patients can find trials on ClinicalTrials.gov. It is important to discuss potential trials with your doctor to understand risks and benefits. Patients should inquire about eligibility and trial locations. New treatments may become available in the next few years, but timelines can vary.
How does this condition affect daily life and activities?
Hemoglobin C disease can impact mobility due to pain episodes and fatigue, affecting self-care and daily activities. Educational adjustments may be necessary for children with frequent absences. Social and emotional challenges include coping with chronic illness and potential stigma. Family members may experience increased caregiving responsibilities. Supportive therapies and adaptations, such as physical therapy and counseling, can help manage these challenges.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Hemoglobin C disease.
Schwab JG, Abelson HT · N Engl J Med · 2004 · PMID: 15470225
- 2.Hemoglobin C disease.
Bain BJ · Am J Hematol · 2015 · PMID: 25488433
- 3.Hemoglobin-C disease.
ORVIS HH, HOLLY PB, SMITH NE · AMA Arch Intern Med · 1955 · PMID: 14387324
- 4.Rod-Shaped Hemoglobin Crystals: Clues to the Diagnosis of Hemoglobin C Disease.
Xu K, Zhao J, Dramé BSI et al. · Indian J Hematol Blood Transfus · 2024 · PMID: 38708168
- 5.[Hemoglobin C].
Trincão C · An Inst Med Trop (Lisb) · 1966 · PMID: 4875632
- 6.Homozygous hemoglobin C disease.
Dalia S, Zhang L · Blood · 2013 · PMID: 24137818
- 7.[Hemoglobin S/C disease].
Iliás L, Viczián E · Orv Hetil · 1982 · PMID: 7133702
- 8.[Hemoglobin C disease: report of 16 Tunisian cases].
Hafsia R, Marrakchi O, Ben Salah N et al. · Tunis Med · 2007 · PMID: 17668575
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-30